6% Yield And Significantly Undervalued: A Closer Look At Organon (NYSE:OGN)


Sechs Prozent auf wei├čem Hintergrund. Isolierte 3D-Illustration

ISerg/iStock via Getty Images

Introduction

It’s time to discover a stock I have never covered before. Organon & Co. (NYSE:OGN) is a woman’s health-focused healthcare spin-off that isn’t doing so well – at least when looking at its stock price.

USD in Million 2021 Weight 2022 Weight

Europe and Canada

1,741 27.6 % 1,631 26.4 %

United States

1,383 21.9 % 1,437 23.3 %

Asia Pacific and Japan

1,173 18.6 % 1,143 18.5 %

China

933 14.8 % 917 14.9 %

Latin America, the Middle East, Russia, and Africa

841 13.3 % 895 14.5 %

Global

233 3.7 % 151 2.4 %



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *